Fellowship in Head and Neck Oncology, Skull Base, and Microvascular Reconstructive Surgery

Massachusetts Eye and Ear/Harvard Medical School

Program Directors:

Daniel G. Deschler, MD, FACS, and Jeremy D. Richmon, MD

Contact Information:

Address
Massachusetts Eye and Ear
243 Charles Street
Boston, MA 02114

Phone
617-573-3502

Fax
617-573-4131

Email
Daniel_Deschler@meei.harvard.edu
Jeremy_Richmon@meei.harvard.edu

Chairman of Department:

D. Bradley Welling, MD, PhD, FACS

Program Coordinator:

Nancy Reardon
nancy_reardon@meei.harvard.edu

Faculty:

Surgery
Daniel G. Deschler, MD, FACS 
Kevin S. Emerick, MD
Derrick T. Lin, MD, FACS
Jeremy D. Richmon, MD
Mark A. Varvares, MD, FACS

Radiation-Oncology
Paul M. Busse, MD
Annie Chan, MD



Medical-Oncology
John R. Clark, MD 
Jung Park, MD
Lori Wirth, MD


Infectious Disease
Marlene Durand, MD 
Miriam Barshak, MD



SLP-speech
Glenn Bunting, CCC-SLP


SLP-swallow
Tessa Goldsmith, CCC-SLP
Allison Holman, CCC-SLP
Racheal Kamer, CCC-SLP

Research
Sara Pai, MD, PhD


Neurosurgery
William T. Curry, MD 
Fred Barker, MD

Radiology
Hugh Curtin, MD
Mary Beth Cunane, MD

Pathology
William Faquin, MD
Peter Sadow, MD

Prosthodontics
Matthew Jackson, DMD

 















Total Number of Positions Available Per Year:

One position

Program Description:

Overview
The Head and Neck Fellowship program at the Mass. Eye and Ear provides advanced clinical training in head and neck oncology, microvascular free flap, and pedicled reconstruction, advanced skull base surgery, transoral robotic surgery, and thyroid and parathyroid surgery. In conjunction with the Massachusetts General Hospital Cancer Center, the fellow will receive comprehensive multidisciplinary training in the management of patients with advanced head and neck cancer. 

Eligibility
The fellow candidate must have completed residency in otolaryngology–head and neck surgery. Candidates should be board-certified or board-eligible, US or Canadian citizens, and be eligible for full Massachusetts State Medical Licensure. 

Clinical Experience
The fellow will oversee the care of all head and neck cancer patients being treated at Mass. Eye and Ear/Mass General. The fellow will assist with the teaching of residents in ablative head and neck surgical procedures. He/she will receive extensive training in free flap and pedicled reconstruction, skull base surgery, and transoral robotic surgery. The fellow is expected to participate in tumor board, multidisciplinary clinic, resident teaching rounds, and specialty tumor board conferences. The fellow will obtain certification in hyperbaric medicine and will rotate in coverage of the Norman Knight Hyperbaric Oxygen Center

Research Opportunities
All fellows are expected to participate in clinical research projects throughout the year. 

Strengths
The Division of Head and Neck Oncology at Mass. Eye and Ear serves as the premier referral center for advanced head and neck cancer care in New England. The high clinical volume provides the fellow with extensive experience in the management of these patients. At the Eye and Ear, the fellow will have the unique opportunity for close interaction with national leaders in the fields of radiology, pathology, and speech and swallow therapy, while the collaborative efforts with Mass General will provide experience with radiation and medical oncology, neurosurgery, thoracic surgery, and surgical oncology. The fellow will receive nationally recognized certification in hyperbaric medicine.


Former Fellows:

Vicente Resto, MD, PhD
Chair, Professor, University of Texas, Galveston
Varesto@UTMB.EDU

Jose Sanclement, MD
Assistant Professor, University of Oklahoma
Jose-Sanclement@ouhsc.edu 

Jeremy Richmon, MD
Associate Professor, Mass. Eye and Ear
Jeremy_Richmon@meei.harvard.edu  

Anthony Nichols, MD
Associate Professor, Division Chief, University of Western Ontario
Anthony.Nichols@lhsc.on.ca 

Vasu Divi, MD
Assistant Professor, Stanford University Medical Center
vdivi@stanford.edu 

Audrey Erman, MD
Assistant Professor, University of Arizona
aerman@oto.arizona.edu 

Alice Lin, MD
Kaiser Permanente, Affiliated Faculty USC, Los Angeles, CA
Alice.Jo.Lin@gmail.com 

Mark Herr, MD
US Army, San Antonio, TX
Marc.W.Herr.mil@mail.mil 

Bharat Yarlagadda, MD
Assistant Professor, Lahey Clinic, Boston University
Bharat.B.Yarlagadda@lahey.org

Neerav Goyal, MD, MPH
Assistant Professor, Penn State Hershey
ngoyal1@hmc.psu.edu 

Tjoson Tjoa, MD
Assistant Professor, UC Irvine
tjosan@gmail.com 

Heather Osborn, MD
Assistant Professor, Yale University
Heather.A.Osborn@gmail.com



Former Fellow Research Projects:

Vicente Resto, MD, PhD
Extent of surgery in the management of locally advanced sinonasal malignancies. Resto VA, Chan A, Deschler DG, Lin DT. Head and Neck. 2007;30(2):222–229.
Pectoralis major flap in composite lateral skull base defect reconstruction. Resto, VA, McKenna, MJ, Deschler, DG. Arch Otolaryngol Head Neck Surg. 2007;133:490–494. 

Jeremy Richmon, MD
National laryngopharyngectomy and reconstructive surgery survey. Richmon JD, Samji HA, Deschler DG. Laryngoscope. 2009 Aug;119(8):1472–8. 

Anthony Nichols, MD
HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Nichols AC, Faquin WC, Westra WH, Mroz EA, Begum S, Clark JR, Rocco JW. Otolaryngol Head Neck Surg. 2009 Feb;140(2):228–34.
Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma. Michaud WA, Nichols AC, Mroz EA, Faquin WC, Clark JR, Begum S, Westra WH, Wada H, Busse PM, Ellisen LW, Rocco JW. Clin Cancer Res. 2009 Mar 1;15(5):1645–54.
Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR, Rocco JW. Clin Cancer Res. 2010 Apr 1;16(7):2138–46.
Surgical salvage of the oropharynx after failure of organ-sparing therapy. Nichols AC, Kneuertz PJ, Deschler DG, Lin DT, Emerick KS, Clark JR, Busse PW, Rocco JW. Head Neck. 2011 Apr;33(4):516–24. 

Vasu Divi, MD
Primary TEP placement in patients with laryngopharyngeal free tissue reconstruction and salivary bypass tube placement. Divi V, Lin DT, Emerick KS, Rocco J, Deschler DG. Otolaryngology—Head and Neck Surgery. 2011;144(3),474–476. 

Mark Herr, MD
Tracheoesophageal voice after total laryngopharyngectomy reconstruction: Jejunum versus radial forearm free flap. Deschler DG, Herr MW, Kmiecik JR, Sethi R, Bunting G. Laryngoscope. 2015 Dec;125(12):2715–21.
Treatment outcomes and prognostic factors including papillomavirus (HPV) for sinonasal undifferentiated carcinoma: A retrospective review. Gray ST, Herr MW, Sethi RKV, Diercks, G, et al. Head Neck. 2015 Mar;37(3):366–74.
Supraclavicular artery island flap for reconstruction of complex parotidectomy, lateral skull base, and total auriculectomy defects. Emerick KS, Herr MW, Lin DT, Santos F, Deschler DG. JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):861–6.
Shoulder function following reconstruction with the supraclavicular artery island flap. Herr MW, Bonanno A, Montalbano LA, Deschler DG, Emerick KS. Laryngoscope. 2014 Nov;124(11):2478–83.
Supraclavicular flap reconstruction following total laryngectomy. Emerick KS, Herr M, Deschler DG. Laryngoscope. 2014 Aug;124(8):1777–82.
Incidence and survival patterns of cranial chordoma in the United States. Chambers KJ, Lin DT, Meier J, Remenschneider A, Herr M, Gray ST. Laryngoscope. 2014 May;124(5):1097–102. 

Bharat Yarlagadda, MD
The time course and microbiology of surgical site infections after head and neck surgery. Durand ML, Yarlagadda B, Rich DL, Lin DT, Emerick KS, Rocco JW, Deschler DG. Laryngoscope. 2015;125(5):1084–9.
Transfusion in head and neck free flap patients: Practice patterns and a comparative analysis by flap type. Puram SV, Yarlagadda B, Sethi R, Muralidhar V, Chambers KJ, Emerick KS, Rocco JW, Lin DT, Deschler DG. Otolaryngol Head Neck Surg. 2015;152(3):449–57.
Head and neck free flap surgical site infections in the era of the Surgical Care Improvement Project. Yarlagadda B, Deschler DG, Rich DL, Lin DT, Emerick KS, Rocco JW, Durand ML. Head Neck. 2015 Jan 12. Epub ahead of print.
Risk factors for surgical site infection after supraclavicular flap reconstruction in patients undergoing major head and neck surgery. Goyal N, Emerick KS, Deschler DG, Lin DT, Yarlagadda B, Rich DL, Durand ML. Head Neck. 2016 Apr 21. Epub ahead of print.
Long-term functional outcomes of total glossectomy with or without total laryngectomy. Lin DT, Yarlagadda B, Sethi RK, Feng AL, Shnayder Y, Ledgerwood LG, Diaz JA, Sinha P, Hanasono MM, Yu P, Skoracki RJ, Lian TS, Patel UA, Leibowitz J, Purdy N, Starmer H, Richmon JD. JAMA Otolaryngol. Head Neck Surg. 2015;141(9):797–803.
Loco-regional control of tongue base adenoid cystic carcinoma with primary resection and radial forearm free flap reconstruction. Yarlagadda B, Meier J, Emerick K, Lin DT, Deschler DG. Ear Nose Throat J. 2017 Jan;96(1):37–40.
Locoregional and free flap reconstruction of the lateral skull base. Richmon JD, Yarlagadda B, Wax MK, Patel U, Diaz J, Lin DT. Head Neck. 2014;37(9):1387–91.
Heat and moisture exchange devices for patients undergoing total laryngectomy. Icuspit P, Yarlagadda B, Garg S, Johnson T, Deschler DG. ORL – Head and Neck Nursing. 2014; 32(1):20–23.
Patient and staff perceptions of social worker consultation before surgical therapy for head and neck cancer. Yarlagadda B, Hatton E, Huettig J, Deschler DG. Health and Social Work. 2015;40(2):120–124.  
Ossifying parotid carcinoma ex pleomorphic adenoma. Mohan S, Puram SV, Yarlagadda B, Nosé V, Deschler DG. Case Rep Otolaryngol. Vol. 2015, Article ID 395358, 2015. 

Neerav Goyal, MD
Minimally invasive removal of mandibular hardware after free flap reconstruction. Goyal N, Deschler DG. Otolaryngol–Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 2015;153(5):888–890.
Management of recurrent HPV-related oropharyngeal cancer. Goyal N, Lin D. Curr Otorhinolaryngol Rep. 2015;3(2):56–62.
Use of the submental vessels for free gracilis muscle transfer for smile reanimation. Goyal N, Jowett N, Dwojak S, et al. Head Neck. June 2016.
Risk factors for surgical site infection after supraclavicular flap reconstruction in patients undergoing major head and neck surgery. Goyal N, Emerick KS, Deschler DG, et al. Head Neck. April 2016.
Clinical outcomes of transoral robotic-assisted surgery for the management of head and neck cancer. Goyal N, Parikh A, Lin D. Robot Surg Res Rev. September 2015:95.
An algorithm for surgical approach to the anterior skull base. Naunheim MR, Goyal N, Dedmon MM, et al. J Neurol Surg Part B Skull Base. 2016;77(4):364–370. 

Heather Osborn, MD
Robotic epiglottopexy for severe epiglottic prolapse limiting decannulation. Colaianni CA, Bowe SN, Osborn HA, Lin DT, Richmon JD, Hartnick CJ. Int J Pediatr Otorhinolaryngol. 2017 Nov;102:157–159.
Risk factors for thirty-day readmission following flap reconstruction of oncologic defects of the head and neck. Osborn HA, Rathi VK, Tjoa T, Goyal N, Yarlagadda BB, Rich DL, Emerick KS, Lin DT, Deschler DG, Durand ML. Laryngoscope. 2017 Aug 29.
Facial nerve sacrifice during parotidectomy: A cautionary tale in pathologic diagnosis. Abt NB, Derakhshan A, Naunheim MR, Osborn HA, Deschler DG. Am J Otolaryngol. 2017 May–Jun;38(3):358–359.
P16 and HPV discordance in oropharyngeal squamous cell carcinoma: What are the clinical implications? Osborn HA, Lin DT. Ann Hematol Oncol 2016; 3(11): 1123.

In submission

Assessing functional outcome in head and neck surgical oncology. Osborn HA, Goldsmith T, Varvares MA. 
Optimizing patient outcomes in carotid body tumor resection with a multi-disciplinary surgical approach. Mohebali J, Osborn HA, Ergul EA, Deschler DG, LaMuraglia GM.



Opportunities to name fellowships are available. Please contact Irene Hammer-McLaughlin, Senior Director of Development in Otolaryngology, for more information at 617-573-3388 or via email at irene_hammer@meei.harvard.edu.